(Q53064857)

11 May 2018

title

Cyclin D1 G870A polymorphism and the risk of hepatocellular carcinoma in a Chinese population. (English)

1 reference

11 May 2018

author name string

Zhangyong Hu

1

1 reference

11 May 2018

Zhipeng Zhou

2

1 reference

11 May 2018

Guolian Xiong

3

1 reference

11 May 2018

Yali Wang

4

1 reference

11 May 2018

Yi Lai

5

1 reference

11 May 2018

Lan Deng

6

1 reference

11 May 2018

Jinliang Yang

7

1 reference

11 May 2018

publication date

26 February 2014

1 reference

11 May 2018

published in

Tumor Biology

1 reference

11 May 2018

volume

35

1 reference

11 May 2018

issue

6

1 reference

11 May 2018

page(s)

5607-5612

1 reference

11 May 2018

https://scigraph.springernature.com/pub.10.1007/s13277-014-1741-3

exact match

0 references

cites work

Global cancer statistics, 2002

1 reference

https://api.crossref.org/works/10.1007%2FS13277-014-1741-3

21 January 2018

Global cancer statistics

1 reference

https://api.crossref.org/works/10.1007%2FS13277-014-1741-3

Molecular mechanisms of hepatocellular carcinoma

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS13277-014-1741-3

Interaction of hepatitis B virus, chemical carcinogen, and genetic susceptibility: multistage hepatocarcinogenesis with multifactorial etiology

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS13277-014-1741-3

Hepatocellular carcinoma: the high-risk patient

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS13277-014-1741-3

Single nucleotide polymorphisms associated with hepatocellular carcinoma in patients with chronic hepatitis B virus infection

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS13277-014-1741-3

Regulation of cyclin D1 gene expression

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS13277-014-1741-3

Frequent alterations of cell cycle regulators in early-stage breast lesions as detected by immunohistochemistry

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS13277-014-1741-3

Cyclin D as a therapeutic target in cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS13277-014-1741-3

Cyclin D1: polymorphism, aberrant splicing and cancer risk

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS13277-014-1741-3

Cyclin D1 splice variants. Differential effects on localization, RB phosphorylation, and cellular transformation

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS13277-014-1741-3

Association of the cyclin D1 A870G polymorphism with advanced colorectal cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS13277-014-1741-3

Cyclin D1 polymorphism and risk for squamous cell carcinoma of the head and neck: a case-control study

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS13277-014-1741-3

Cyclin D1 gene polymorphism is associated with an increased risk of urinary bladder cancer.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS13277-014-1741-3

Increased risk of prostate cancer associated with AA genotype of cyclin D1 gene A870G polymorphism

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS13277-014-1741-3

Cyclin D1 G870A polymorphism is associated with an increased risk of hepatocellular carcinoma in the Turkish population: case-control study.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS13277-014-1741-3

Cell cycle control and cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS13277-014-1741-3

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS13277-014-1741-3

Cyclin D1 and human neoplasia

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS13277-014-1741-3

Cyclin D1 splice variants: polymorphism, risk, and isoform-specific regulation in prostate cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS13277-014-1741-3

Association of the cyclin D1 gene G870A polymorphism with susceptibility to sporadic renal cell carcinoma.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS13277-014-1741-3

The 870G>A polymorphism of the cyclin D1 gene is not associated with breast cancer.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS13277-014-1741-3

Polymorphisms in DNA repair and metabolic genes in bladder cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS13277-014-1741-3

MDM2 SNP309T>G polymorphism increases susceptibility to hepatitis B virus-related hepatocellular carcinoma in a northeast Han Chinese population

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS13277-014-1741-3

Association of polymorphisms in the cyclin D1 and XPD genes and susceptibility to cancers of the upper aero-digestive tract

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS13277-014-1741-3

Cyclin D1 polymorphism and expression in patients with squamous cell carcinoma of the head and neck

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS13277-014-1741-3

Amplification and overexpression of the cyclin D1 gene in aggressive human hepatocellular carcinoma

21 January 2018

1 reference

12 December 2020

Lack of association between CCND1 G870A polymorphism and risk of esophageal squamous cell carcinoma.

1 reference

12 December 2020

CYCLIN D1 as a genetic modifier in hereditary nonpolyposis colorectal cancer

1 reference

12 December 2020

Alternate splicing produces a novel cyclin D1 transcript

1 reference

12 December 2020

Polymorphisms in cyclin D1 gene and hepatocellular carcinoma

1 reference

12 December 2020

Amplification and overexpression of cyclin D1 in human hepatocellular carcinoma

1 reference

12 December 2020

Large-scale search of single nucleotide polymorphisms for hepatocellular carcinoma susceptibility genes in patients with hepatitis C

1 reference

12 December 2020

Expression of cyclin D1 and retinoblastoma protein in colorectal cancer

1 reference

12 December 2020

PRAD-1 (CCND1)/cyclin D1 oncogene amplification in primary head and neck squamous cell carcinoma

1 reference

12 December 2020

10.1007/S13277-014-1741-3

Identifiers

DOI

1 reference

11 May 2018

1 reference

11 May 2018